The study is being performed by the Institute for Health Research at the University of Notre Dame in Western Australia.
Presently, ten women are involved in the study, though the team plans to expand to a total of 50 participants.
As more and more companies seek to understand all that cannabis can do, it should come as no surprise that researchers want to see what kind of health benefits the substance can have. Much of the information circulating nowadays includes ways that THC can be detrimental to the user's health . However, there is much more to the story. The body is created with the endocannabinoid system, which uses receptors in the central nervous system and the immune system to gain benefits from the use of THC and CBD.
The Food and Drug administration has already approved the use of CBD in a drug called Epidiolex, which treats two forms of childhood epilepsy. Now, the Institute for Health Research at the University of Notre Dame in Western Australia is starting new research on the way that cannabis can benefit sufferers of dementia.
The UNDA has gone through two years of planning to make this study possible , which will be using human patients, rather than Lab Rats. All of the cannabinoid extract involved in this study will come from MGC Pharma, which processes produces and grows the plants. Individuals involved in the study will be using an oral spray that contains a 3:2 ratio of THC to CBD.
At this point, the study has already followed 10 women that are experiencing severe dementia, but that's not where the study ends. Instead, the study will eventually include a total of 50 participants through the next year, which makes it one of the largest studies for this particular sector of the industry. Their primary focus been selecting participants involves individuals who presently live accredited care facilities that take care of the elderly and the disabled, which is a decision that is meant to keep the patients in the study safe.
Team lead Dr. Amanda Timler states that the preliminary observations indicate that the subjects are experiencing reductions in both behavioral concerns and limited movements, despite only being two months into the study. The cannabis use for these patients has also helped with low appetite, insomnia, aggression, and general agitation. These are all common symptoms that arise for patients that suffer with dementia.
Dr. Timler recently spoke with Cannabis Business Times, regarding the plans that she has for the future, as well as her past history and experience involving cannabis. Dr. Timler remarked,
“For me, I have a great interest in the area of medicinal cannabis as there are so many therapeutic properties that seem to benefit a range of conditions, so I'm interested to see how this medication can help to treat dementia as it is a complex condition, with no cure.”
She also expressed that she had spoken with many family members who “just want someone to talk to” about their experience with the lack of effectiveness of the medication their loved ones are getting.